DSCAM-AS1 and breast cancer: Transcriptome analyses clearly indicate DSCAM-AS1 involvement in the regulation of splicing and 3′-end usage, an aspect that is considered increasingly important in cancer biology, and that also correlates strongly with the observation that BC cells express an abnormal, and subtype-specific, variety of circRNAs [73].